| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity
|
Lemmens, V.E.P.P.
|
|
|
16 |
5 |
p. 767-772
|
artikel
|
| 2 |
An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM)
|
Smith, T.J.
|
|
|
16 |
5 |
p. 825-833
|
artikel
|
| 3 |
Bisphosphonates in breast cancer
|
Coleman, R.E.
|
|
|
16 |
5 |
p. 687-695
|
artikel
|
| 4 |
Can bleomycin toxicity in the treatment of testis cancer be batch related?
|
Birtle, A.J.
|
|
|
16 |
5 |
p. 837
|
artikel
|
| 5 |
Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology Group
|
Xiros, N.
|
|
|
16 |
5 |
p. 773-779
|
artikel
|
| 6 |
Clinical course of thoracic cancers in Hodgkin's disease survivors
|
Das, P.
|
|
|
16 |
5 |
p. 793-797
|
artikel
|
| 7 |
cTnT can be a useful marker for early detection of anthracycline cardiotoxicity
|
Kilickap, S.
|
|
|
16 |
5 |
p. 798-804
|
artikel
|
| 8 |
Cyclin E expression in breast cancer: predicting germline BRCA1 mutations, prognosis and response to treatment
|
Chappuis, P.O.
|
|
|
16 |
5 |
p. 735-742
|
artikel
|
| 9 |
Deep vein thrombosis in cancer: the scale of the problem and approaches to management
|
Falanga, A.
|
|
|
16 |
5 |
p. 696-701
|
artikel
|
| 10 |
Dying Well—a guide to enabling a good death, 2nd edition
|
Catane, R.
|
|
|
16 |
5 |
p. 843
|
artikel
|
| 11 |
High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trial
|
Coombes, R.C.
|
|
|
16 |
5 |
p. 726-734
|
artikel
|
| 12 |
Is high-dose chemotherapy with peripheral stem cell rescue a suitable option for elderly patients affected by aggressive non-Hodgkin's lymphoma?
|
Bernardi, D.
|
|
|
16 |
5 |
p. 837-838
|
artikel
|
| 13 |
Liver does not care about age
|
Turrini, O.
|
|
|
16 |
5 |
p. 836-837
|
artikel
|
| 14 |
Management of anaemia in patients with breast cancer: role of epoetin
|
Leonard, R.C.
|
|
|
16 |
5 |
p. 817-824
|
artikel
|
| 15 |
National and international nicotine dependence
|
Gray, N.
|
|
|
16 |
5 |
p. 681-682
|
artikel
|
| 16 |
Oncology for medical students: a new ESO educational avenue
|
Pavlidis, N.
|
|
|
16 |
5 |
p. 840-841
|
artikel
|
| 17 |
Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I–II study
|
Seium, Y.
|
|
|
16 |
5 |
p. 762-766
|
artikel
|
| 18 |
Predictors of quality of life in newly diagnosed melanoma and breast cancer patients
|
Lehto, U.-S.
|
|
|
16 |
5 |
p. 805-816
|
artikel
|
| 19 |
Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) study
|
González-Martín, A.J.
|
|
|
16 |
5 |
p. 749-755
|
artikel
|
| 20 |
Report of a European consensus workshop to develop recommendations for the optimal use of 90Y-ibritumomab tiuxetan (Zevalin®) in lymphoma
|
Hagenbeek, A.
|
|
|
16 |
5 |
p. 786-792
|
artikel
|
| 21 |
Risk profile and outcome in Hodgkin's lymphoma: is obesity beneficial?
|
Landgren, O.
|
|
|
16 |
5 |
p. 838-840
|
artikel
|
| 22 |
Skin rash and good performance status predict improved survival with gefitinib in patients with advanced non-small cell lung cancer
|
Mohamed, M.K.
|
|
|
16 |
5 |
p. 780-785
|
artikel
|
| 23 |
Table of Contents
|
|
|
|
16 |
5 |
p. ii-iii
|
artikel
|
| 24 |
Tailoring a tailored treatment: the importance of fine-tuning on the patient
|
Tondini, C.
|
|
|
16 |
5 |
p. 683-685
|
artikel
|
| 25 |
The effects of capecitabine in Raynaud's disease: a case report
|
Coward, J.
|
|
|
16 |
5 |
p. 835-836
|
artikel
|
| 26 |
The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L)
|
Wasan, K.M.
|
|
|
16 |
5 |
p. 707-715
|
artikel
|
| 27 |
Time trends in the treatment and survival of recurrences from colorectal cancer
|
Guyot, F.
|
|
|
16 |
5 |
p. 756-761
|
artikel
|
| 28 |
Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor
|
Colleoni, M.
|
|
|
16 |
5 |
p. 716-725
|
artikel
|
| 29 |
Tobacco dependence in the general population in Italy
|
Gallus, S.
|
|
|
16 |
5 |
p. 703-706
|
artikel
|
| 30 |
Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF
|
Andersson, J.
|
|
|
16 |
5 |
p. 743-748
|
artikel
|
Tijdschrift beschrijving